1. Nafazatrom (BAY g 6575) an inhibitor of cellular lipoxygenase activity;Busse,1982
2. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size;Clark;J. Pharmacol. Meth.,1980
3. Evolution of epicardial R wave voltage and myocardial ischemia following experimental coronary artery thrombosis: Effects of nafazatrom;Fiedler;Naunyn-Schmiedeb. Arch. Pharmacol.,1982
4. The effects of oral nafazatrom (BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia;Fiedler;Basic Res. Cardiol.,1983
5. Protective actions of nafazatrom in traumatic shock;Lefer;Arzneim. Forsch.,1982